Inverse probability weighting leads to more accurate incidence estimates for healthcare associated infections in intensive care units, results from two national surveillance systems.
IF 4.3 3区 材料科学Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Costanza Vicentini, Roberta Bussolino, Matilde Perego, Daniela Silengo, Fortunato D'Ancona, Stefano Finazzi, Carla M Zotti
{"title":"Inverse probability weighting leads to more accurate incidence estimates for healthcare associated infections in intensive care units, results from two national surveillance systems.","authors":"Costanza Vicentini, Roberta Bussolino, Matilde Perego, Daniela Silengo, Fortunato D'Ancona, Stefano Finazzi, Carla M Zotti","doi":"10.1016/j.jhin.2024.10.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Two main approaches are employed to monitor healthcare associated infections (HAIs): longitudinal surveillance, which allows to measure incidence rates, and point prevalence surveys (PPS). PPS are less time-consuming; however, they are affected by length-biased sampling, which can be corrected through inverse probability weighting. We assessed the accuracy of this method by analysing data from two Italian national surveillance systems.</p><p><strong>Methods: </strong>Ventilator associated pneumonia (VAP) and central-line associated bloodstream infection (CLABSI) incidence measured through a prospective surveillance system (GiViTI) was compared to incidence estimates obtained through conversion of crude and inverse probability weighted prevalence of the same HAIs in intensive care units (ICUs) measured through a PPS. Weighted prevalence rates were obtained after weighting all patients inversely proportional to their time-at-risk. Prevalence rates were converted into incidence per 100 admissions using an adapted version of the Rhame and Sudderth formula.</p><p><strong>Results: </strong>Overall, 30988 patients monitored through GiViTI, and 1435 patients monitored through the PPS were included. A significant difference was found between incidence rates estimated based on crude VAP and CLABSI prevalence and measured through GiViTI (relative risk, RR 2.5 and 3.36; 95% confidence interval, CI 1.42 - 4.39 and 1.33 - 8.53, p = 0.006 and 0.05 respectively). Conversely, no significant difference was found between incidence rates estimated based on weighted VAP and CLABSI prevalence and measured through GiViTI (p = 0.927 and 0.503 respectively).</p><p><strong>Conclusion: </strong>When prospective surveillance is not feasible, our simple method could be useful to obtain more accurate incidence rates from PPS data.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhin.2024.10.009","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Two main approaches are employed to monitor healthcare associated infections (HAIs): longitudinal surveillance, which allows to measure incidence rates, and point prevalence surveys (PPS). PPS are less time-consuming; however, they are affected by length-biased sampling, which can be corrected through inverse probability weighting. We assessed the accuracy of this method by analysing data from two Italian national surveillance systems.
Methods: Ventilator associated pneumonia (VAP) and central-line associated bloodstream infection (CLABSI) incidence measured through a prospective surveillance system (GiViTI) was compared to incidence estimates obtained through conversion of crude and inverse probability weighted prevalence of the same HAIs in intensive care units (ICUs) measured through a PPS. Weighted prevalence rates were obtained after weighting all patients inversely proportional to their time-at-risk. Prevalence rates were converted into incidence per 100 admissions using an adapted version of the Rhame and Sudderth formula.
Results: Overall, 30988 patients monitored through GiViTI, and 1435 patients monitored through the PPS were included. A significant difference was found between incidence rates estimated based on crude VAP and CLABSI prevalence and measured through GiViTI (relative risk, RR 2.5 and 3.36; 95% confidence interval, CI 1.42 - 4.39 and 1.33 - 8.53, p = 0.006 and 0.05 respectively). Conversely, no significant difference was found between incidence rates estimated based on weighted VAP and CLABSI prevalence and measured through GiViTI (p = 0.927 and 0.503 respectively).
Conclusion: When prospective surveillance is not feasible, our simple method could be useful to obtain more accurate incidence rates from PPS data.